No abstract available
Keywords:
COVID-19; IL-6; SARS-CoV-2; treatment; zinc.
MeSH terms
-
Adjuvants, Pharmaceutic
-
Antimalarials / therapeutic use
-
Betacoronavirus / enzymology
-
Betacoronavirus / immunology*
-
COVID-19
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / immunology*
-
Coronavirus Infections / mortality
-
Coronavirus Infections / virology
-
DNA-Directed RNA Polymerases / antagonists & inhibitors
-
Dietary Supplements
-
Drug Synergism
-
Homeostasis / immunology
-
Humans
-
Interferon Type I / immunology
-
Interleukin-6 / genetics
-
Interleukin-6 / immunology
-
Pandemics
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / immunology*
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / virology
-
Polymorphism, Genetic
-
SARS-CoV-2
-
Virus Replication / drug effects
-
Zinc / deficiency
-
Zinc / immunology*
-
Zinc / pharmacology
-
Zinc / therapeutic use
Substances
-
Adjuvants, Pharmaceutic
-
Antimalarials
-
IL6 protein, human
-
Interferon Type I
-
Interleukin-6
-
DNA-Directed RNA Polymerases
-
Zinc